Loncat ke konten utama
Depan
Kontak
  • Berita Terkini
    • 2015
      • January 2015
      • February 2015
    • 2014
      • January 2014
        • PROTELOS / OSSEOR: European Committee for Pharmacovigilance Recommendation
      • February 2014
      • March 2014
        • Cellectis and Servier Announce Collaboration in Alloganeic Cell Therapy
      • April 2014
        • Servier Research Group announces the death of President-Founder Dr. Jacques Servier
      • May 2014
      • June 2014
      • July 2014
      • August 2014
      • September 2014
      • October 2014
        • Servier and CTI Biopharma Announce Exclusive License and Collaboration Agreement to Develop and Commercialize Pixuvri
      • November 2014
      • December 2014
        • GeNeuro and Servier Sign Partnership to Develop First Medicine Addressing a Causal Factor of Multiple Sclerosis
    • 2013
      • January 2013
      • February 2013
      • March 2013
      • April 2013
      • May 2013
        • National Institute for Clinical Excellence (NICE) guidance endorsed Coralan® for the management of heart failure patients
      • June 2013
      • July 2013
        • AMGEN AND SERVIER ANNOUNCE PRODUCT COLLABORATION
      • August 2013
      • September 2013
        • The European Society of Cardiology Released the New Guidelines for the Management of Stable Coronary Artery Disease Patients...
    • 2012
      • November 2012
      • Desember 2012
  • Produk
    • Produk portofolio
  • Perusahaan
    • Tiga prinsip pedoman kami
    • Mengubah ide menjadi tindakan
    • Terikat oleh motivasi yang kuat
    • Gambaran utama
    • Servier Key Facts
  • Penelitian
    • Industri modern
    • Kerjasama yang menguntungkan
    • Penelitian
  • Peluang Karir
    • Bergabung bersama Servier
    • Lowongan kerja
  • Internasional
    • Servier di seluruh dunia
  • Servier Medical Art

Anda di sini

Depan » Berita Terkini » 2015

2015

PROTELOS / OSSEOR: European Committee for Pharmacovigilance Recommendation
Post date: 01/27/2014 - 18:15
Cellectis and Servier Announce Collaboration in Alloganeic Cell Therapy : UCART19 to treat lukimia and 5 product candidates targeting solid tumors
Post date: 03/10/2014 - 16:30
Servier Key Facts
Post date: 03/11/2014 - 09:44
April 2014
Post date: 04/14/2014 - 11:16
Servier Research Group announces the death of President-Founder Dr. Jacques Servier
Post date: 04/17/2014 - 13:39
  • English
  • Bahasa Indonesia

Form pencarian

Servier didirikan pada tahun 1954, adalah grup farmasi pertama yang independen. Kami hadir di 140 negara, dengan karyawan lebih dari 21.000 karyawan, termasuk hampir 3000 karyawan bekerja di R&D.

© 2013 PT SERVIER INDONESIA, an incorporated company of Servier. All Rights Reserved.
Servier tidak menjual produk melalui internet.
Melaporkan efek samping dari obat.

 Privasi Data       Hubungi Kami

Perhatian :  kami merekomendasikan untuk menggunakan Internet Explorer versi 9 hingga yang terakhir untuk mendapatkan tampilan yang lebih baik